These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 107195)

  • 1. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cellular immunity in Chagas' disease.
    Toledo Barros MA; Amato Neto V; Mendes E; Mota I
    Clin Exp Immunol; 1979 Nov; 38(2):376-80. PubMed ID: 118840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens.
    Teixeira AR; Santos-Buch CA
    Immunology; 1975 Mar; 28(3):401-10. PubMed ID: 805088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagas' disease: trends in immunological research and prospects for immunoprophylaxis.
    Teixeira AR
    Bull World Health Organ; 1979; 57(5):697-710. PubMed ID: 120233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man.
    Teixeira AR; Teixeira ML; Santos-Buch CA
    Am J Pathol; 1975 Jul; 80(1):163-80. PubMed ID: 808136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease.
    Añez N; Crisante G; da Silva FM; Rojas A; Carrasco H; Umezawa ES; Stolf AM; Ramírez JL; Teixeira MM
    Trop Med Int Health; 2004 Dec; 9(12):1319-26. PubMed ID: 15598264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).
    Lelchuk R; Cardoni RL; Fuks AS
    Clin Exp Immunol; 1977 Dec; 30(3):434-8. PubMed ID: 414867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
    Zúñiga E; Montes C; Barbieri G; Gruppi A
    Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens.
    Silva AA; Roffe E; Marino AP; dos Santos PV; Quirico-Santos T; Paiva CN; Lannes-Vieira J
    Clin Immunol; 1999 Jul; 92(1):56-66. PubMed ID: 10413653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
    Ribeiro BM; Crema E; Rodrigues V
    Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
    Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA
    Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease.
    Hontebeyrie-Joskowicz M; Said G; Milon G; Marchal G; Eisen H
    Eur J Immunol; 1987 Jul; 17(7):1027-33. PubMed ID: 2440690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and epidemiologic studies of Chagas' disease in rural communities of Oaxaca, Mexico, and an eight-year followup: II. Chila.
    Goldsmith RS; Zárate RJ; Zárate LG; Morales G; Kagan I; Drickey R; Jacobson LB
    Bull Pan Am Health Organ; 1992; 26(1):47-59. PubMed ID: 1600437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.